Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Histopathology

• Publication date

  2018-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/his.13508PMID 29495092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

  2017cited by this paper
• Pancreatic Cancer: “A Riddle Wrapped in a Mystery inside an Enigma”

  2017cited by this paper
• Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer

  2017cited by this paper
• Addressing the challenges of pancreatic cancer: future directions for improving outcomes.

  2015influential reference
• Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma

  2015cited by this paper
• Detailed analysis of epithelial‐mesenchymal transition and tumor budding identifies predictors of long‐term survival in pancreatic ductal adenocarcinoma

  2015cited by this paper
• Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis

  2015cited by this paper
• Pancreatic cancer: systemic combination therapies for a heterogeneous disease.

  2014influential reference
• Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer

  2013cited by this paper
• Pancreas cancer on the rise: are we up to the challenge?

  2013influential reference
• Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients

  2013cited by this paper
• Tumour budding is a strong and independent prognostic factor in pancreatic cancer.

  2013cited by this paper
• Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.

  2013cited by this paper
• Tumour budding: a promising parameter in colorectal cancer

  2012cited by this paper
• Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations

  2011cited by this paper
• Ductal Adenocarcinoma of the Pancreas.

  2011cited by this paper
• Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

  2011cited by this paper
• Tumor Budding as a Strong Prognostic Indicator in Invasive Ampullary Adenocarcinomas

  2010cited by this paper
• Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro‐oesophageal junction cancers

  2010cited by this paper
• Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer

  2009cited by this paper
• EMT: when epithelial cells decide to become mesenchymal-like cells.

  2009cited by this paper
• Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy

  2009cited by this paper
• Histopathologic determinants of regional lymph node metastasis in early colorectal cancer

  2008cited by this paper
• Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

  2008cited by this paper
• Tumour budding in colorectal carcinoma

  2007cited by this paper
• Role of APAF‐1, E‐cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

  2007cited by this paper
• Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2

  2006cited by this paper
• Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer.

  2005cited by this paper
• REporting recommendations for tumour MARKer prognostic studies (REMARK).

  2005cited by this paper
• REporting recommendations for tumour MARKer prognostic studies (REMARK)

  2005cited by this paper
• Risk factors for an adverse outcome in early invasive colorectal carcinoma.

  2004cited by this paper
• Predictors of extrahepatic recurrence after resection of colorectal liver metastases

  2004cited by this paper
• Tumour `budding' as an index to estimate the potential of aggressiveness in rectal cancer

  2002cited by this paper
• Prognostic Factors in Cancer

  1995cited by this paper
• Prognostic value of tumor “budding” in patients with colorectal cancer

  1993cited by this paper
• The Exocrine Pancreas.

  1980cited by this paper

• Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome

  2025cites this paper
• Comparative Prognostic Roles of β-Catenin Expression and Tumor–Stroma Ratio in Pancreatic Cancer: Neoadjuvant Chemotherapy vs. Upfront Surgery

  2025cites this paper
• Tumor Budding and E‐Cadherin Loss as Robust Prognostic Markers in Pancreatic Ductal Adenocarcinoma: A Study in a Turkish Patient Cohort

  2025cites this paper
• A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee.

  2025cites this paper
• Prognostic Significance of Tumour Budding and Tumour-infiltrating Lymphocytes in Gallbladder Carcinoma

  2025cites this paper
• Multicenter study on tumor budding in lung squamous cell carcinoma: comparison between biopsy and resection with interobserver variability assessment.

  2024cites this paper
• Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes

  2024cites this paper
• Tumor Budding Is an Independent Adverse Prognostic Factor of Pancreatic Ductal Adenocarcinoma Patients Treated by Resection After Preoperative Chemoradiotherapy

  2024influential citation
• Impact of the International Tumor Budding Consensus Conference Recommendations in Oral Cancer

  2024cites this paper
• Network dynamics and therapeutic aspects of mRNA and protein markers with the recurrence sites of pancreatic cancer

  2024cites this paper
• Prognostic significance of tumor budding in pancreatic carcinoma: Digitalized image approach evaluation using artificial intelligence.

  2024cites this paper
• Prognostic significance of tumour budding in noncolorectal gastrointestinal tract and pancreatobiliary tract: a systematic review and meta‐analysis

  2024cites this paper
• The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma

  2024cites this paper
• Spatial heterogeneity of immune regulators drives dynamic changes of local immune responses, affecting disease outcomes in pancreatic cancer.

  2024cites this paper
• Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas

  2023cites this paper
• Tumor Budding and Poor Prognosis in Oral Cancer: A Systematic Review and Meta-Analysis

  2023cites this paper
• Tumor budding as a predictor of disease-free survival in patients with cholangiocarcinoma

  2023cites this paper
• Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy

  2023cites this paper
• Case Report Pancreatic Ductal Adenocarcinoma and “Pseudo-IPMN”

  2022cites this paper
• Tumor Budding as a Marker for Poor Prognosis and Epithelial–Mesenchymal Transition in Lung Cancer: A Systematic Review and Meta-Analysis

  2022cites this paper
• Post‐neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage‐ and regression‐grade independent prognostic information in intestinal‐type gastric adenocarcinoma

  2022cites this paper
• Impact of molecular surgical margin analysis on the prediction of pancreatic cancer recurrences after pancreaticoduodenectomy

  2021cites this paper
• Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer

  2021cites this paper
• Prognostic Role of Tumor‐Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma

  2021cites this paper
• Pancreatic Cancers with High Grade Tumor Budding Exhibit Hallmarks of Diminished Anti-Tumor Immunity

  2021cites this paper
• Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system

  2021cites this paper
• Tumour budding and its clinical implications in gastrointestinal cancers

  2020cites this paper
• Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups

  2020cites this paper
• Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study

  2020cites this paper
• Malignant epithelial/exocrine tumors of the pancreas

  2020cites this paper
• FAK activity in cancer‐associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer

  2020cites this paper
• Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis

  2020cites this paper
• Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition

  2019cites this paper
• A classification based on tumor budding and immune score for patients with hepatocellular carcinoma

  2019cites this paper
• Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung—a single-center analysis of 354 cases

  2019cites this paper
• Does evaluation of tumour budding in diagnostic biopsies have a clinical relevance? A systematic review

  2019cites this paper
• Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma

  2019cites this paper
• Separation of low versus high grade Crohn's disease-associated small bowel carcinomas is improved by invasive front prognostic marker analysis.

  2019cites this paper
• Clinical Scenarios Emerging from Combined Immunophenotypic, Molecular and Morphologic Analysis of Pancreatic Cancer: The Good, the Bad and the Ugly Scenario

  2019cites this paper
• A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding

  2019cites this paper
• World Journal of Gastrointestinal Oncology

  year unknowncites this paper